Physician profile
Sinan Simsir
NPI 1528142445
$3,271.79
in general payments reported to CMS, 2019-2025
28 companies · $333 in 2025
The $333 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $387 · 2020: $230 · 2021: $1,100 · 2022: $1,091 · 2023: $63.62 · 2024: $67.06 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $463.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $650.83 | 2020-2024 | Impella |
| Preventric Diagnostics, INC. | $539.82 | 2022 | |
| Abbott Laboratories | $471.34 | 2019-2025 | Navitor |
| Medtronic, INC. | $267.85 | 2021 | |
| Edwards Lifesciences Corporation | $189.98 | 2022-2025 | Konect Resilia, Sapien 3 Ultra Resilia |
| Bayer Healthcare Pharmaceuticals INC. | $153.89 | 2022 | |
| Atricure, INC. | $147.55 | 2019-2021 | |
| Angiodynamics, INC. | $140.17 | 2021 | |
| Janssen Pharmaceuticals, INC | $98.80 | 2021-2022 | |
| Amgen INC. | $83.60 | 2021-2022 | |
| Intuitive Surgical, INC. | $74.00 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $62.01 | 2021-2022 | |
| Getinge USA Sales, LLC | $60.11 | 2020-2022 | |
| Baxter Healthcare | $45.84 | 2021 | |
| Surmodics, INC. | $42.20 | 2023 | Sublime Radial Access Guide Sheath, Sublime Radial Access 018 Rx Pta Dilatation Catheter, Pounce Thrombectomy |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $28.63 | 2020-2021 | |
| Pulmonx Corporation | $28.41 | 2022 | |
| Davol INC. | $24.75 | 2021 | |
| Alnylam Pharmaceuticals INC. | $22.20 | 2021 | |
| Cmp Pharma, INC. | $17.87 | 2021 | |
| Medtronic Vascular, INC. | $17.75 | 2020 | |
| Lantheus Medical Imaging, INC. | $17.00 | 2022 | |
| Pfizer INC. | $15.47 | 2022 | |
| Merck Sharp & Dohme LLC | $15.24 | 2022 | |
| Akcea Therapeutics, INC. | $14.53 | 2019 | |
| Portola Pharmaceuticals, LLC | $14.53 | 2019 | |
| Esperion Therapeutics, INC. | $13.79 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sinan Simsir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.